1. Home
  2. GNLX vs GAN Comparison

GNLX vs GAN Comparison

Compare GNLX & GAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • GAN
  • Stock Information
  • Founded
  • GNLX 2001
  • GAN 1999
  • Country
  • GNLX United States
  • GAN United States
  • Employees
  • GNLX N/A
  • GAN N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • GAN Computer Software: Programming Data Processing
  • Sector
  • GNLX Health Care
  • GAN Technology
  • Exchange
  • GNLX Nasdaq
  • GAN Nasdaq
  • Market Cap
  • GNLX 85.0M
  • GAN 83.2M
  • IPO Year
  • GNLX 2023
  • GAN 2020
  • Fundamental
  • Price
  • GNLX $5.34
  • GAN $1.75
  • Analyst Decision
  • GNLX Strong Buy
  • GAN
  • Analyst Count
  • GNLX 4
  • GAN 0
  • Target Price
  • GNLX $18.25
  • GAN N/A
  • AVG Volume (30 Days)
  • GNLX 386.7K
  • GAN 250.5K
  • Earning Date
  • GNLX 03-31-2025
  • GAN 03-12-2025
  • Dividend Yield
  • GNLX N/A
  • GAN N/A
  • EPS Growth
  • GNLX N/A
  • GAN N/A
  • EPS
  • GNLX N/A
  • GAN N/A
  • Revenue
  • GNLX $8,000.00
  • GAN $134,024,000.00
  • Revenue This Year
  • GNLX N/A
  • GAN $12.70
  • Revenue Next Year
  • GNLX N/A
  • GAN $10.67
  • P/E Ratio
  • GNLX N/A
  • GAN N/A
  • Revenue Growth
  • GNLX N/A
  • GAN N/A
  • 52 Week Low
  • GNLX $1.60
  • GAN $1.17
  • 52 Week High
  • GNLX $8.67
  • GAN $1.90
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 72.84
  • GAN 36.04
  • Support Level
  • GNLX $4.10
  • GAN $1.72
  • Resistance Level
  • GNLX $5.89
  • GAN $1.85
  • Average True Range (ATR)
  • GNLX 0.54
  • GAN 0.04
  • MACD
  • GNLX 0.14
  • GAN -0.01
  • Stochastic Oscillator
  • GNLX 79.70
  • GAN 16.67

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About GAN GAN Limited

GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.

Share on Social Networks: